STRO Historical PE Ratio image   This STRO PE ratio history page last updated 3/27/2024
STRO PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/25/2024
3.270.52-1.78NA
Q3 2023
11/13/2023
2.07-0.81-2.91NA
Q2 2023
8/10/2023
4.34-0.64-2.47NA
Q1 2023
5/15/2023
5.88-0.85-2.38NA
Q4 2022
3/30/2023
4.48-0.61-2.37NA
Q3 2022
11/8/2022
7.15-0.37-1.76NA
Q2 2022
8/8/2022
6.19-0.55-2.22NA
Q1 2022
5/9/2022
5.03-0.84-2.34NA
Q4 2021
2/28/2022
8.92-0.83-2.29NA
Q3 2021
11/10/2021
21.58-0.67-2.94NA
Q2 2021
8/9/2021
18.37-0.13-1.82NA
Q1 2021
5/7/2021
19.29-0.66-2.29NA
Q4 2020
3/18/2021
23.93-1.48-2.47NA
Q3 2020
11/5/2020
14.410.45-1.64NA
Q2 2020
8/6/2020
8.55-0.60-2.65NA
Q1 2020
5/11/2020
10.11-0.84-2.65NA
Q4 2019
3/16/2020
6.19-0.65-2.43NA
Q3 2019
11/8/2019
10.98-0.56-1.85NA
Q2 2019
8/14/2019
8.56-0.60-22.55NA
Q1 2019
5/15/2019
10.15-0.62NANA
Q4 2018
4/1/2019
11.59-0.07NANA
Q3 2018
11/14/2018
11.62-21.26NANA
STRO Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/25/2024
3.270.522.081.6
Q3 2023
11/13/2023
2.07-0.81-3.24NA
Q2 2023
8/10/2023
4.34-0.64-2.56NA
Q1 2023
5/15/2023
5.88-0.85-3.40NA
Q4 2022
3/30/2023
4.48-0.61-2.44NA
Q3 2022
11/8/2022
7.15-0.37-1.48NA
Q2 2022
8/8/2022
6.19-0.55-2.20NA
Q1 2022
5/9/2022
5.03-0.84-3.36NA
Q4 2021
2/28/2022
8.92-0.83-3.32NA
Q3 2021
11/10/2021
21.58-0.67-2.68NA
Q2 2021
8/9/2021
18.37-0.13-0.52NA
Q1 2021
5/7/2021
19.29-0.66-2.64NA
Q4 2020
3/18/2021
23.93-1.48-5.92NA
Q3 2020
11/5/2020
14.410.451.808.0
Q2 2020
8/6/2020
8.55-0.60-2.40NA
Q1 2020
5/11/2020
10.11-0.84-3.36NA
Q4 2019
3/16/2020
6.19-0.65-2.60NA
Q3 2019
11/8/2019
10.98-0.56-2.24NA
Q2 2019
8/14/2019
8.56-0.60-2.40NA
Q1 2019
5/15/2019
10.15-0.62-2.48NA
Q4 2018
4/1/2019
11.59-0.07-0.28NA
Q3 2018
11/14/2018
11.62-21.26-85.04NA
Quotes delayed 20 minutes

Email EnvelopeFree STRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sutro Biopharma (STRO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

STRR PE Ratio History
STSA PE Ratio History
STTK PE Ratio History
SUPN PE Ratio History
SURF PE Ratio History
SVRA PE Ratio History
SWAV PE Ratio History
SWTX PE Ratio History
SYBX PE Ratio History
SYK PE Ratio History
On this page we presented the STRO PE Ratio History information for Sutro Biopharma' stock. The average STRO PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average STRO PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this STRO PE ratio history result, against the recent PE: when this page was posted on 3/26/2024, the most recent closing price for STRO had been 4.18, and the most recent quarterly earnings result, annualized, was 2.08. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent STRO PE on 3/26/2024 based on annualized quarterly EPS was 2.0. Based on STRO's history, that recent PE is low relative to the historical average, with the recent PE 58.3% lower than the historical average PE across our data set for Sutro Biopharma.

For self directed investors doing their due diligence on STRO or any other given stock, valuation analysis for STRO can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Sutro Biopharma PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for STRO. Thanks for visiting, and the next time you need to research STRO PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of SHAP, HVBC Options Chain, GPK Average Annual Return.

 

STRO PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.